All Type of News
Promoting off-label drug uses is illegal
It is common for doctors to prescribe drugs for conditions they aren't specifically approved for, but in many cases there is not enough evidence to justify the practice, the Ministry of Food and Drug Safety (MFDS) sai...
Austria Biotechnology Forum 2013 to open
Scores of biopharmaceutical industry experts at home and abroad will gathered in Seoul on May 27 to hold a forum on the future of the biopharmaceutical industries in Korea and Austria.
The Austria Biotechnology For...
Drugmakers fear possible fallout of Tylenol snafu
Domestic drug firms are now under full alert to inspect the manufacturing, product management and quality control procedures on their medicinal products as the quality control (QC) team of Janssen Korea was at the cen...
Hanmi picked as one of successful enterprises to lead global business
Hanmi Pharmaceutical Co. has been chosen as one of the nation’s successful businesses, along with other companies, to incessantly push ahead with global projects, Korea International Trade Association (KITA) said rece...
HIV drug delivery patch in the Pipeline, Samjin Pharm says
Samjin Pharmaceutical said Tuesday that its U.S. partner ImQuest Biosciences is developing a skin patch to deliver antiretroviral medications containing pyrimidinedione, citing a latter’s recent presentation at the 20...
Daewoong to export Easyef to TurkeyDaewoong has signed a signed a contract with a Turkish company to export its diabetic foot ulcer therapy called "Easyef" for the next five years, officials said Tuesday.
The...
|
Government urged to overhaul dental fees
The Korean Dental Association (KDA) is demanding more say in deciding medical fees and are seeking better management conditions for dentists.
In its first meeting with the National Health Insurance Corporation on T...
Bayer rekindling strategic alliance flame
Bayer Korea is actively seeking strategic alliances with domestic pharmaceutical firms using its popular over-the-counter (OTC) products.
Bayer Korea has recently decided to transfer its OTC drugs, including Sarido...
Korean drug firms’ cash ratio falls in 2012
Korea's overall cash asset ratio deteriorated in 2012 from a year earlier due to the government’s forced price cut for drugs and other medical products covered by national health insurance, a local pharmaceutical port...
Domestic drug makers skimping on R&D investment
Despite their relatively large assets, the nation’s 50 Korean pharmaceutical companies spend considerably less on research and development (R&D), industry data showed recently.
Citing the data released by the Fina...
